GS-444217 | GS-444217 : ATP-competitive inhibitor of MAP3K5
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds
Vendors

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
MAP3K5
  • IC50:2.87 ± 0.85 nM
  • Kd:4.1 nM
  • Ki:0.32 ± 0.03 nM
  • Kd:2.9 ± 0.8 nM
>300 nM to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
Selectivity of GS-444217 (1 μM) for ASK1 was determined using KINOMEscan binding assay against 442 k ...
Selectivity Assessment Description:
GS-444217 demonstrated high selectivity for binding to ASK1 versus the other kinases in the panel. T ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
The activity of GS-444217 was evaluated using the BioMAP Diversity PLUS panel up to 10 uM
Selectivity Assessment Description:
At a concentration of 1 μM, a dose that suppresses ASK1 and p38 activation in HEK293T cells, the onl ...

Potency
Cellular
In Vitro

MAP3K5

Mode of Action: ATP-competitive inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1172/JCI99768

In Vivo Validations

Rat
Dose: 10 mg/Kg
Route of delivery: Oral
Plasma half life: 2.07 ± 0.05 h
Cmax: 25,234 ± 6,462 nM
Area Under the Curve:: 100,207 ± 35,996 nM·hr
Bioavailability: 89.6%

DOI Reference: 10.1172/JCI99768

Dose: 30 mg/Kg
Route of delivery: Oral
Plasma half life: 2.84 ± 0.98 h
Cmax: 65,546 ± 10,239 nM
Area Under the Curve:: 365,622 ± 45,458 nM·hr
Bioavailability: 109%

DOI Reference: 10.1172/JCI99768

Chemical Information

Molecular Formula C23H23N7O
SMILEs CC(C)n1cnnc1-c1cccc(NC(=O)c2cc(-n3cnc(C4CC4)c3)ccn2)c1
InChI InChI=1S/C23H23N7O/c1-15(2)30-14-26-28-22(30)17-4-3-5-18(10-17)27-23(31)20-11-19(8-9-24-20)29-12-21(25-13-29)16-6-7-16/h3-5,8-16H,6-7H2,1-2H3,(H,27,31)
Molecular weight 413.20 Da
AlogP 4.236400000000002
HBond acceptors 8
HBond donors 1
Atoms 54

Expert Reviews


No SERP comments found for GS-444217

Probe GS-444217 is in the process of SERP review.

Please continue to check back for new reviews and commentary.

If you would like to explore AI-generated evaluations, you may wish to visit the page for this compound on our collaborator website